Eli Lilly files $500M NAFTA suit against Canada over drug patents
 

Eli Lilly is accusing Canada of violating its obligations to foreign investors under the North American Free Trade Agreement by allowing its courts to invalidate patents for two of its drugs.


More...

From http://start.westnet.ca News
News Provided By
WestNet Wireless Internet